现在时间是:
当前位置:首 页 >> News>> English>> 文章列表

The 6th PVRI Workshops and Debates 2013

作者:pkupv   发布时间:2012-08-24 20:03:57   浏览次数:6974

 

Scientific Program (CURRENTLY STILL UNDER DEVELOPMENT)
The 6th PVRI Workshops and Debates 2013
 
Istanbul   21st – 25th January 2013
 
Monday 21st January 2013
13:00 - 17:30 Annual Board of Directors and Advisors meeting
14:30- 21:30 Special PVRI Symposium on Paediatric & Congenital Heart Diseases PVDs  
16:00-19:00 Special symposium for Turkish Cardiologists (in Turkish) 
19:00- 21:30 Teaching Symposium: Management of Pulmonary hypertension, Basic lectures and update on the management of pulmonary vascular diseases
Chaired by Ioana Preston and TBA
1.    Clinical diagnosis of Pulmonary Hypertension
2.    The value of imaging in the diagnosis and management of Pulmonary Hypertension
3.    Current therapies in the management of Pulmonary Hypertension
4.    Illustrative case reports
 
Tuesday 22nd January 2013
08:00- 10:00  PVRI Annual General meeting
10:00- 10:30   Coffee
Special Symposium: Pulmonary Hypertension Academic Research Consortium       
1.     10:30- 11:00 Introductory remarks
Chaired by Stuart Rich.
2.     11:00- 13:00 Establishing a PVRI Clinical Trial Consortium. Follow-up from the May 2012 Bethesda meeting
Chaired by John Newman. Discussants TBA
13:00 Lunch
3.     14:00- 15:30 Clinical Classification and Phenotyping in patients with Pulmonary Hypertension
Chaired by Simon Gibbs and TBA. Discussants: David Langleben, Stefan Graf, and others.
4.     16:00- 17:30 Clinical trials in non-PAH PVD (endpoints, standardization etc.)
Chaired by Ardeschir Ghofrani and TBA. Discussants TBA
This session will be a follow up of the PH-ARC (2nd FDA/PVRI meeting in Washington). It will be attended by regulatory agencies and various key industry representatives from all over the world. 
 
Wednesday 23rd January 2013
07:00- 08:00     Special Meeting PVRI Review Editorial Board (invitation only)
08:00- 09:00     Peter Raymond Memorial Lecture: Pulmonary Veno-Occlusive Disease 
Chaired by TBA. Invited lecturer: Patricia Thistlethwaite
09:00- 10:30      Congenital Heart Diseases in PHT
Chaired by Antonio Augusto Lopes and TBA. Discussants TBA (Congenital Heart Diseases taskforce)
10:30- 11:00     Coffee
11:00- 13:00     The role of inflammation in PVD: cause or outcome.
Chaired by Andrew Peacock & Paul Corris. Discussants TBA
The session will be devoted to assessing the role of inflammation in PVD, & the way inflammation can be a therapeutic target.
13:00 Lunch
14:00- 17:30 Special Symposium:  Developing new medications for pulmonary hypertension in the 21st Century (from hypothesis to first-time-in-humans)
Chaired by Simon Campbell and Martin Wilkins
 
1.Structural modification to improve target selectivity - Discussants: Simon Campbell and others
A review of the development of sildenafil based on the structure of zaprinast.
 
2. Why drugs fail in clinical development -  Discussants: Martin Wilkins and others
Lessons from disappointing results with statins, VIP and terguride
Need for better molecular definition of patients with PAH 
 
3. What are we looking for in the development of the new Pulmonary Hypertension drugs? Examples: 
 
a. Tyrosine kinase inhibitors – Discussants: Ralph Schermuly and others
What can we learn from imatinib, dasatinib, and other tyrosine kinase inhibitors by comparing their targets?
What target molecules are expressed in the stressed myocardium that predispose to side effects? 
 
b. HDACs – Discussants: Kurt Stenmark and others
 
This is a special session to assess why some class of drugs can induce PVD while others have a therapeutic effect. It will examine how the structure of the chemical moieties can interfere with the signalling mechanism, and the way to modify that to approach therapeutic goals
19:00-21:00 Special Group meetings
·       Pulmonary Circulation Editorial Board
·       Joint Paediatrics & Congenital Heart Diseases Taskforces
·       Database Taskforces
·       Regional Meetings
 
Thursday 24th January 2013
07:00- 08:00 Special Session PVRI Educational Initiatives (With breakfast. Interested delegates welcome)
08:00- 10:00 Exercise testing in PVD
Chaired by Aaron Waxman and TBA. 
1.            Historical perspective on exercise testing - David Kilpatrick  
2.            PA pressure flow relationship during exercise in normal and senescent man - Robert Naeije  
3.            Maximum incremental invasive CPET for detection of early PAH - David Systrom  
4.            Exercise and pulmonary vascular dynamics in obstructive lung disease - Anton Vonk Noordgraaf  
5.            Exercise training and rehav in patients with PH, safe and effective - Aaron Waxman  
This session will discuss and debate the role of exercise in the diagnosis and managements of patients with pulmonary hypertension
10:00-  10:30 Coffee
10:30- 13:00 Pulmonary Hypertension in the Eastern Mediterranean Region
Chaired by Majdy Idrees and Paul Hassoun. Discussants TBA
This session examines the spectrum of pulmonary hypertension in the EMT region and how this might differ from the rest of the world. It will also concentrate on the pattern of management in this region of the world.       
13:00 Lunch
14:00FREE TIME
19:30  PVD History talk and PVRI Achievement award followed by the Gala Dinner
 
Friday 25th January 2013
08:00- 10:00 Pulmonary Vascular Disease in Heart Failure:
Chaired by Stephen Archer and TBA. Discussants TBA
The pathological spectrum of PVD in Heart failure, and its impact on the management of these patients
10:00- 10:30 Coffee
10:30- 13:00 The new emerging diagnostic tools for PVD: echo, EMR CT scan
Chaired by Stefano Ghio and TBA. Discussants TBA
This is a follow up for the discussion of the diagnostic tools for the management of pulmonary hypertension that we started in Cape Town, where we discussed the right heart catheterization in both adults and children. Next year we will concentrate in the non-invasive methods.
13:00 Lunch
14:00- 15:45 Abstract sessions
Chaired by Marc Pritzker and TBA
 (Abstracts session in Cape Town have instigated rewarding dicussion. We encourage submission of your work, including unfinished work that you would like to discuss; feedback of all Fellows is welcomed)
15:45- 16:00  Coffee
16:00- 17:00 Special Session: Update of the Panama Classification of Paediatric Pulmonary Hypertension
Chaired by Ian Adatia and Maria Jesus del Cerro
A report for the deliberation of the Paediatrics and congenital heart diseases Taskforces
 






上一篇:没有了    下一篇:没有了

Copyright ©2019    北京大学肺血管病先锋论坛 All Right Reserved.

技术支持:自助建站 | 领地网站建设 |短信接口 |燕窝 版权所有 © 2005-2019 lingw.net.粤ICP备16125321号 -5